28 November 2017 - Deborah Wilkes
Archived
Teva’s new president and chief executive officer Kare Schultz is restructuring the Israeli generics company around three geographic regions. Each region will manage the entire portfolio – including generic, specialty and OTC products – with “full end-to-end profit and loss accountability”.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.